Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome-Reference-Cited by-同舟云学术

Non-myeloablative conditioning with busulfan before hematopoietic stem cell transplantation leads to phenotypic correction of murine Bernard-Soulier syndrome

Published:2014-08-26 Issue:10 Volume:12 Page:1726-1732
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Kanaji S.¹²,Fahs S. A.¹,Ware J.³,Montgomery R. R.¹⁴⁵,Shi Q.¹⁴⁵

Affiliation:

1. Blood Research Institute; Blood Center of Wisconsin; Milwaukee WI USA

2. The Scripps Research Institute; La Jolla CA USA

3. University of Arkansas for Medical Sciences; Little Rock AR USA

4. Department of Pediatrics; Medical College of Wisconsin; Milwaukee WI USA

5. Children's Research Institute; Children's Hospital of Wisconsin; Milwaukee WI USA

Funder

National Institutes of Health

Children's Hospital Foundation

MACC Fund

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12673/fullpdf

Reference25 articles.

1. Sur une nouvelle varie′te′ de dystrophie thrombocytaire-he′morragipare conge′nitale;Bernard;Sem Hop,1948

2. Bernard-Soulier syndrome;Lopez;Blood,1998

3. Correction of murine Bernard-Soulier syndrome by lentivirus-mediated gene therapy;Kanaji;Mol Ther,2012

4. TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions;Hill-Kayser;Bernard- Transplant,2011

5. Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A;Shi;J Thromb Haemost,2007

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model;Journal for ImmunoTherapy of Cancer;2020-11

2. Gene Therapy for Platelet Disorders;Platelets;2019

3. Ex Vivo Selection of Transduced Hematopoietic Stem Cells for Gene Therapy of β-Hemoglobinopathies;Molecular Therapy;2018-02

4. Gene Therapy;Platelets in Thrombotic and Non-Thrombotic Disorders;2017

5. The contribution of mouse models to the understanding of constitutional thrombocytopenia;Haematologica;2016-07-31